Vertical Research initiated coverage on Amphenol with a new price target
$APH
Electrical Products
Technology
Vertical Research initiated coverage of Amphenol with a rating of Hold and set a new price target of $65.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/4/2024 | $80.00 → $71.00 | Buy → Neutral | BofA Securities |
| 7/23/2024 | $65.00 | Hold | Vertical Research |
| 5/20/2024 | $150.00 | Buy | Seaport Research Partners |
| 4/9/2024 | $125.00 | Hold | Jefferies |
| 1/5/2024 | $117.00 | Buy | Citigroup |
| 10/5/2023 | $93.00 | Outperform | Exane BNP Paribas |
| 5/19/2023 | $91.00 → $77.00 | Outperform → Neutral | Credit Suisse |
| 12/13/2022 | $93.00 | Outperform | Credit Suisse |
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE:APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial busin
10-K - AMPHENOL CORP /DE/ (0000820313) (Filer)
8-K - AMPHENOL CORP /DE/ (0000820313) (Filer)
8-K - AMPHENOL CORP /DE/ (0000820313) (Filer)
BofA Securities downgraded Amphenol from Buy to Neutral and set a new price target of $71.00 from $80.00 previously
Vertical Research initiated coverage of Amphenol with a rating of Hold and set a new price target of $65.00
Seaport Research Partners initiated coverage of Amphenol with a rating of Buy and set a new price target of $150.00
TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE:APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial busin
CommScope (NASDAQ:COMM), a global leader in network connectivity, announced today the closing of the transaction to sell its Outdoor Wireless Networks (OWN) segment and Distributed Antenna Systems (DAS) business to Amphenol Corporation (NYSE:APH). The Company previously announced the signing of a definitive agreement for the transaction on July 18, 2024. The proceeds from the sale will be used to pay fees and expenses associated with the transaction and to repay all outstanding amounts under the Company's asset-backed revolving credit facility, to repay in part the Company's 4.750% Senior Secured Notes due 2029 and to repay in full the Company's 6.000% Senior Secured Notes due 2026. In
Amphenol Corporation (NYSE:APH) today announced it had completed the acquisition of CommScope's (NASDAQ:COMM) Outdoor Wireless Networks (OWN) and Distributed Antenna Systems (DAS) businesses. "The acquisition of the OWN and DAS businesses brings to Amphenol a strong portfolio of innovative and advanced technologies for communications networks," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "We are excited to welcome nearly 4,000 talented employees to the Amphenol family and look forward to further supporting our customers who are developing next-generation wireless networks around the world." Amphenol expects the OWN and DAS businesses to generate full-year 2025
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
Amphenol Corporation (NYSE:APH) today announced it had completed the acquisition of CommScope's (NASDAQ:COMM) Outdoor Wireless Networks (OWN) and Distributed Antenna Systems (DAS) businesses. "The acquisition of the OWN and DAS businesses brings to Amphenol a strong portfolio of innovative and advanced technologies for communications networks," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "We are excited to welcome nearly 4,000 talented employees to the Amphenol family and look forward to further supporting our customers who are developing next-generation wireless networks around the world." Amphenol expects the OWN and DAS businesses to generate full-year 2025
Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the first quarter 2025 dividend on its Common Stock in the amount of $0.165 per share at its meeting held on January 29, 2025. The Company will pay this first quarter 2025 dividend on April 9, 2025 to shareholders of record as of March 18, 2025. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 co
Fourth Quarter 2024 Highlights: Sales of $4.3 billion, up 30% in U.S. dollars and 20% organically compared to the fourth quarter of 2023 GAAP Diluted EPS of $0.59, up 44% compared to prior year Adjusted Diluted EPS of $0.55, up 34% compared to prior year GAAP and Adjusted Operating Margin of 22.1% and 22.4%, respectively Operating and Free Cash Flow of $847 million and $648 million, respectively Full Year 2024 Highlights: Sales of $15.2 billion, up 21% in U.S. dollars and 13% organically compared to the full year 2023 GAAP Diluted EPS of $1.92, up 24% compared to prior year Adjusted Diluted EPS of $1.89, up 25% compared to prior year GAAP and Adjusted Operating
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)